FDA Inspection 1177571 — Xytex Laboratories

Xytex Laboratories — FEI 3014254056

The FDA completed an inspection of Xytex Laboratories on Aug 5, 2022 in Athens, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Aug 5, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Athens, GA (United States)